A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.

Published Date: 24 May 2023

A clinical trial combining two medications was recently carried out in patients with recurrent, high-grade glioblastoma (GBM) by the Mays Cancer Center at The University of Texas Health Science Center at San Antonio. Mays Cancer Center.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

2.

Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

3.

Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer

4.

Alkem introduces cetuximab under the trade name Cetuxa in India.

5.

A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot